Loading…
Radiological and clinical improvement in a patient with COVID-19 pneumonia postconvalescent plasma transfusion: A case report
Currently, there are no approved specific antiviral agents for novel coronavirus disease 2019 (COVID-19). Convalescent plasma has not yet been approved for use in patients with COVID-19 infection; however, it is regulated as an investigational product. This is a case report of a 55-year-old male, wi...
Saved in:
Published in: | Radiology case reports 2020, Vol.15 (11), p.2171-2174 |
---|---|
Main Authors: | , , , , |
Format: | Report |
Language: | English |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Currently, there are no approved specific antiviral agents for novel coronavirus disease 2019 (COVID-19). Convalescent plasma has not yet been approved for use in patients with COVID-19 infection; however, it is regulated as an investigational product. This is a case report of a 55-year-old male, with COVID-19 pneumonia who has received convalescent plasma as part of a treatment plan which showed significant radiological and clinical improvement post-treatment. |
---|---|
ISSN: | 1930-0433 1930-0433 |
DOI: | 10.1016/j.radcr.2020.07.031 |